Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
21,509 Breast Cancer
clinical trials

Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Tunnell Cancer Center at Beebe Medical Center
mi
from
Lewes, DE
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
mi
from
Seattle, WA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Sanford Cancer Center at Sanford USD Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Langlade Memorial Hospital
mi
from
Antigo, WI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Billings Clinic - Downtown
mi
from
Billings, MT
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Boulder Community Hospital
mi
from
Boulder, CO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Wood County Oncology Center
mi
from
Bowling Green, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Highline Medical Center Cancer Center
mi
from
Burien, WA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Rocky Mountain Oncology
mi
from
Casper, WY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Louis A. Weiss Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
CCOP - Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Samaritan North Cancer Care Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Grandview Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Doylestown Hospital Cancer Center
mi
from
Doylestown, PA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Elkhart Clinic, LLC
mi
from
Elkhart, IN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Elmhurst Memorial Hospital
mi
from
Elmhurst, IL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Community Cancer Center
mi
from
Elyria, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Swedish Medical Center
mi
from
Englewood, CO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Cancer Center of Kansas-Independence
mi
from
Independence, KS
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Cleveland Clinic Cancer Center
mi
from
Independence, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Kalispell Medical Oncology at KRMC
mi
from
Kalispell, MT
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Charles F. Kettering Memorial Hospital
mi
from
Kettering, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
CCOP - Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
HealthEast Cancer Care at St. John's Hospital
mi
from
Maplewood, MN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Vince Lombardi Cancer Clinic - Marinette
mi
from
Marinette, WI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Mercy Memorial Hospital - Monroe
mi
from
Monroe, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Community Cancer Center of Monroe
mi
from
Monroe, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Cancer Center at Ball Memorial Hospital
mi
from
Muncie, IN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
St. Luke's - Roosevelt Hospital Center - St.Luke's Division
mi
from
New York, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Beth Israel Medical Center - Petrie Division
mi
from
New York, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Creighton University Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Immanuel Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
St. Joseph Hospital Regional Cancer Center - Orange
mi
from
Orange, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Palo Alto Medical Foundation
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
St. Joseph's Hospital and Medical Center
mi
from
Paterson, NJ
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Pottstown Memorial Regional Cancer Center
mi
from
Pottstown, PA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
St. Mary - Corwin Regional Medical Center
mi
from
Pueblo, CO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Reid Hospital & Health Care Services
mi
from
Richmond, IN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Humphrey Cancer Center at North Memorial Outpatient Center
mi
from
Robbinsdale, MN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Lakeside Cancer Specialists, PLLC
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Park Nicollet Cancer Center
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Cancer Center of Kansas, PA - Salina
mi
from
Salina, KS
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
St. Francis Cancer Center at St. Francis Medical Center
mi
from
Shakopee, MN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
St. Nicholas Hospital
mi
from
Sheboygan, WI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Memorial Hospital of South Bend
mi
from
South Bend, IN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
St. John's Regional Health Center
mi
from
Springfield, MO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Toledo Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Medical University of Ohio Cancer Center
mi
from
Toledo, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Fox Chase Virtua Health Cancer Program at Virtua West Jersey
mi
from
Voorhees, NJ
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Exempla Lutheran Medical Center
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Cancer Center of Kansas, PA - Medical Arts Tower
mi
from
Wichita, KS
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
CCOP - Wichita
mi
from
Wichita, KS
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Riverview Uw Cancer Center
mi
from
Wisconsin Rapids, WI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling, Phase II
Updated: 12/6/2012
Ruth G. McMillan Cancer Center at Greene Memorial Hospital
mi
from
Xenia, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
Status: Enrolling, Phase
Updated: 12/31/1969
Woodhull Medical and Mental Health Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
Status: Enrolling, Phase
Updated: 12/31/1969
Bellevue Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 7/17/2013
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Lymphedema Clinical Trial
Two Pneumatic Compression Devices in the Treatment of Lower Extremity Lymphedema
Status: Enrolling, Phase IV
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Lymphedema Clinical Trial
Two Pneumatic Compression Devices in the Treatment of Lower Extremity Lymphedema
Status: Enrolling, Phase IV
Updated: 12/31/1969
Fletcher Allen Health Care, Inc., University of Vermont
mi
from
Colchester, VT
Click here to add this to my saved trials
Lymphedema Clinical Trial
Two Pneumatic Compression Devices in the Treatment of Lower Extremity Lymphedema
Status: Enrolling, Phase IV
Updated: 12/31/1969
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Histology of Functional Density in Postmenopausal Breast
Status: Enrolling, Phase
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer
Status: Enrolling
Updated: 7/5/2012
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders
Status: Enrolling, Phase
Updated: 12/31/1969
Wound Care Clinic at CHI St. Luke's The Woodland's Hospital
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Tennessee Cancer Specialists Oncology Clinical Trials Center for Biomedical Research
mi
from
Knoxville, TN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
Status: Enrolling, Phase III
Updated: 6/24/2014
Rocky Mountain Cancer Centers-Lakewood
mi
from
Lakewood, CO
Click here to add this to my saved trials
Oncology Clinical Trial
MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer
Status: Enrolling
Updated: 12/4/2012
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Oncology Clinical Trial
Mithramycin for Lung, Esophagus, and Other Chest Cancers
Status: Enrolling, Phase II
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Status: Enrolling, Phase I
Updated: 12/31/1969
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LY3023414 in Participants With Advanced Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LY3023414 in Participants With Advanced Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Bixby Medical Center
mi
from
Adrian, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
AnMedical Health Cancer Center
mi
from
Anderson, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sutter Cancer Centers Radiation Oncology Services-Auburn
mi
from
Auburn, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Spectrum Health Big Rapids Hospital
mi
from
Big Rapids, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Alabama at Birmingham Cancer Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Alphonsus Cancer Care Center-Boise
mi
from
Boise, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Medical Center
mi
from
Canton, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Elkhart Clinic, LLC
mi
from
Elkhart, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Piedmont Fayette Hospital
mi
from
Fayetteville, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Orion Cancer Care
mi
from
Findlay, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Parkview Regional Medical Center
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Atrium Medical Center - Middletown Regional Hospital
mi
from
Franklin, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Research Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Luke's Hospital, Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sparrow Hospital
mi
from
Lansing, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Beebe Medical Center
mi
from
Lewes, DE
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Barnabas Medical Center
mi
from
Livingston, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
mi
from
Maumee, OH
Click here to add this to my saved trials